Clinical Trials Directory

Trials / Conditions / Sarcomatous Mesothelioma

Sarcomatous Mesothelioma

8 registered clinical trials studyying Sarcomatous Mesothelioma.

StatusTrialSponsorPhase
WithdrawnAMG 102, Pemetrexed Disodium, and Cisplatin in Treating Patients With Malignant Pleural Mesothelioma
NCT01105390
National Cancer Institute (NCI)Phase 2
CompletedPXD101 as Second-Line Therapy in Treating Patients With Malignant Mesothelioma of the Chest That Cannot Be Rem
NCT00365053
National Cancer Institute (NCI)Phase 2
CompletedCediranib Maleate in Treating Patients With Malignant Mesothelioma That Cannot Be Removed By Surgery
NCT00309946
National Cancer Institute (NCI)Phase 2
CompletedS0509 - AZD2171 in Treating Patients With Malignant Pleural Mesothelioma That Cannot Be Removed By Surgery
NCT00243074
National Cancer Institute (NCI)Phase 2
CompletedSorafenib Tosylate in Treating Patients With Malignant Mesothelioma.
NCT00107432
National Cancer Institute (NCI)Phase 2
CompletedErlotinib in Treating Patients With Malignant Mesothelioma of the Lung
NCT00039182
National Cancer Institute (NCI)Phase 2
CompletedCombination Chemotherapy With or Without Bevacizumab in Treating Patients With Malignant Mesothelioma
NCT00027703
National Cancer Institute (NCI)Phase 2
CompletedGefitinib in Treating Patients With Malignant Mesothelioma
NCT00025207
National Cancer Institute (NCI)Phase 2